Robert Uzzo
机构：Fox Chase Cancer Center
发表论文 7 篇 · 总被引 26 次 · h-index 3
代表论文
- LBA66 IMmotion010: Efficacy and safety from the phase III study of atezolizumab (atezo) vs placebo (pbo) as adjuvant therapy in patients with renal cell carcinoma (RCC) at increased risk of recurrence after resection (2022 · Annals of Oncology · 被引 14)
- Circulating tumor DNA (ctDNA) to guide response-adapted bladder preservation in muscle invasive bladder cancer (MIBC): Integrated analysis of the RETAIN trials. (2026 · Journal of Clinical Oncology · 被引 9)
- Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell Carcinoma (2026 · European Urology · 被引 3)
- Pathologic response after neoadjuvant therapy in renal cell carcinoma using irRVT criteria. (2026 · Journal of Clinical Oncology)
- Circulating tumor DNA analysis from the prospective pT0 study of systematic endoscopic evaluation in patients undergoing radical cystectomy for bladder cancer. (2026 · Journal of Clinical Oncology)
- Assessing the impact of cardiovascular disease and ADT on survival disparities in prostate cancer. (2026 · Journal of Clinical Oncology)